# EDGAR Filing Document

**Accession Number:** 0001992121
**File Stem:** 0001213900-26-048113
**Filing Date:** 2026-4
**Character Count:** 6970
**Document Hash:** bc5bde5c3b50ecfb91b92c001bfa3ec4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-048113.hdr.sgml**: 20260427

**ACCESSION NUMBER**: 0001213900-26-048113

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260424

**FILED AS OF DATE**: 20260427

**DATE AS OF CHANGE**: 20260427

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Capone Vincent S.
- **CENTRAL INDEX KEY:** 0001992121

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40058
- **FILM NUMBER:** 26902459

**MAIL ADDRESS:**
- **STREET 1:** 1620 GRASSHOPPER LANE
- **CITY:** LOWER GWYNEDD
- **STATE:** PA
- **ZIP:** 19002
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Spectral AI, Inc.
- **CENTRAL INDEX KEY:** 0001833498
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 2515 MCKINNEY AVE #1000
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201
- **BUSINESS PHONE:** (212) 492-3000

**MAIL ADDRESS:**
- **STREET 1:** 2515 MCKINNEY AVE #1000
- **CITY:** DALLAS
- **STATE:** TX
- **ZIP:** 75201

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Rosecliff Acquisition Corp I
- **DATE OF NAME CHANGE:** 20201123

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Capone Vincent S.<br><sub>(Last) (First) (Middle)</sub><br>2515 MCKINNEY AVENUE<br>SUITE 1000<br><sub>(Street)</sub><br>DALLAS, TX 75201<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-04-24 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Spectral AI, Inc. [ MDAI ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2026-04-24 |  | A |  | 100000<sup>(1)</sup> | A | $0.00 | 286450 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| ISO | $4.47 |  |  |  |  |  |  | <sup>(2)</sup> | 2032-05-06 | Common Stock | 60955 |  | 60955 | D |  |
| NQSO | $4.36 |  |  |  |  |  |  | <sup>(2)</sup> | 2032-05-06 | Common Stock | 6939 |  | 6939 | D |  |
| ISO | $4.48 |  |  |  |  |  |  | <sup>(3)</sup> | 2033-04-13 | Common Stock | 6014 |  | 6014 | D |  |
| NQSO | $4.48 |  |  |  |  |  |  | <sup>(3)</sup> | 2033-04-13 | Common Stock | 12027 |  | 12027 | D |  |
| ISO | $5.54 |  |  |  |  |  |  | <sup>(4)</sup> | 2033-06-01 | Common Stock | 6466 |  | 6581 | D |  |
| NQSO | $5.54 |  |  |  |  |  |  | <sup>(4)</sup> | 2033-06-01 | Common Stock | 12932 |  | 13162 | D |  |
| NQSO | $1.2 |  |  |  |  |  |  | <sup>(5)</sup> | 2035-04-01 | Common Stock | 75000 |  | 75000 | D |  |
| Restricted Stock Units | $1.84 |  |  |  |  |  |  | <sup>(6)</sup> | 2036-04-20 | Common Stock | 100000 |  | 100000 | D |  |

---

### Footnotes:

(1) The total includes 100,000 restricted stock units ("RSUs"), which are fully vested and were issued on 4/24/2026.

(2) The stock options are fully vested and exercisable.

(3) 100% of the stock options are vested as of the date hereof.

(4) 33% of the stock options vested on 6/29/2024, 33% vested on 6/29/2025, and the remainder vest on 6/25/2026.

(5) 33% vested on 4/1/2026, and the remainder vest upon the achievement of certain milestones.

(6) 50% of the RSUs, 2026. 50% of the RSU will vest on April 1, 2027.

**Signature:** /s/ Vincent S. Capone  
**Date:** 2026-04-27

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**